Use Of Pertuzumab And Trastuzumab Emtansine In Adult Patients With Her2-Positive Metastatic Or Locally Recurrent Unresectable Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab emtansine (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms KNOWHER
- 31 Aug 2018 Biomarkers information updated
- 11 Jan 2018 Planned End Date changed from 1 Dec 2017 to 31 Dec 2018.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Oct 2018.